Introduction:
Varicella-Zoster Virus VZV is a DNA virus belonging to the herpes virus
family, responsible for two clinical conditions. The primary
infection generates varicella (chickenpox). Secondary infection also
known as reactivation of latent VZV induces shingle [1].
Recently, following the massive administration of COVID-19 vaccines to a
large population, several adverse events following immunization AEFI
have been observed that were not initially mentioned in the safety data
sheet of these vaccines or detected in clinical trials prior to its
marketing [2]. Post-marketing, sporadic case reports and a
series of VZV reactivations have been reported [3].
In this study, we aimed to present and analyze the characteristics of
VZV reactivation cases after COVID-19 vaccination.